ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the androgen receptor
- Genentech, United States
- Novartis Institutes for BioMedical Research, United States
- Harvard Medical School, United States
- Novartis Institutes for Biomedical Research, United States
- Organovo, United States
- NIBR, United States
- Laboratoires Servier, France
- Celgene Avilomics Research, United States
Peer review process
This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.
History
- Version of Record published
- Accepted Manuscript updated
- Accepted Manuscript published
- Accepted
- Received
